Toll Free: 1-888-928-9744
Published: Apr, 2014 | Pages:
38 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Idenix Pharmaceuticals, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Idenix Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Idenix Pharmaceuticals, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Idenix Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Idenix Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Idenix Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Idenix Pharmaceuticals, Inc.'s pipeline products Reasons to buy - Evaluate Idenix Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Idenix Pharmaceuticals, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Idenix Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Idenix Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Idenix Pharmaceuticals, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Idenix Pharmaceuticals, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Idenix Pharmaceuticals, Inc. Snapshot 5 Idenix Pharmaceuticals, Inc. Overview 5 Key Information 5 Key Facts 5 Idenix Pharmaceuticals, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Idenix Pharmaceuticals, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Partnered Products 10 Partnered Products/Combination Treatment Modalities 11 Idenix Pharmaceuticals, Inc. - Pipeline Products Glance 12 Idenix Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 12 Phase II Products/Combination Treatment Modalities 12 Phase I Products/Combination Treatment Modalities 13 Idenix Pharmaceuticals, Inc. - Early Stage Pipeline Products 14 IND/CTA Filed Products/Combination Treatment Modalities 14 Idenix Pharmaceuticals, Inc. - Drug Profiles 15 samatasvir 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 IDX-21437 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 IDX-21459 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 IDX-20963 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Idenix Pharmaceuticals, Inc. - Pipeline Analysis 19 Idenix Pharmaceuticals, Inc. - Pipeline Products by Target 19 Idenix Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 20 Idenix Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 21 Idenix Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 22 Idenix Pharmaceuticals, Inc. - Recent Pipeline Updates 23 Idenix Pharmaceuticals, Inc. - Dormant Projects 28 Idenix Pharmaceuticals, Inc. - Discontinued Pipeline Products 29 Discontinued Pipeline Product Profiles 29 IDX-102 29 IDX-184 29 IDX-19368 29 IDX-19370 29 IDX-320 30 Idenix Pharmaceuticals, Inc. - Company Statement 31 Idenix Pharmaceuticals, Inc. - Locations And Subsidiaries 35 Head Office 35 Other Locations & Subsidiaries 35 Appendix 37 Methodology 37 Coverage 37 Secondary Research 37 Primary Research 37 Expert Panel Validation 37 Contact Us 38 Disclaimer 38
List of Tables Idenix Pharmaceuticals, Inc., Key Information 5 Idenix Pharmaceuticals, Inc., Key Facts 5 Idenix Pharmaceuticals, Inc. - Pipeline by Indication, 2014 7 Idenix Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014 8 Idenix Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014 9 Idenix Pharmaceuticals, Inc. - Partnered Products in Pipeline, 2014 10 Idenix Pharmaceuticals, Inc. - Partnered Products/ Combination Treatment Modalities, 2014 11 Idenix Pharmaceuticals, Inc. - Phase II, 2014 12 Idenix Pharmaceuticals, Inc. - Phase I, 2014 13 Idenix Pharmaceuticals, Inc. - IND/CTA Filed, 2014 14 Idenix Pharmaceuticals, Inc. - Pipeline by Target, 2014 19 Idenix Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2014 20 Idenix Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2014 21 Idenix Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2014 22 Idenix Pharmaceuticals, Inc. - Recent Pipeline Updates, 2014 23 Idenix Pharmaceuticals, Inc. - Dormant Developmental Projects,2014 28 Idenix Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2014 29 Idenix Pharmaceuticals, Inc., Other Locations 35 Idenix Pharmaceuticals, Inc., Subsidiaries 36
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.